Alas2em4Mdf
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Alas2em4Mdf |
| Name: |
aminolevulinic acid synthase 2, erythroid; endonuclease-mediated mutation 4, Mark D Fleming |
| MGI ID: |
MGI:7780122 |
| Synonyms: |
Alas2 ins14, V550Efs |
| Gene: |
Alas2 Location: ChrX:149330443-149353614 bp, + strand Genetic Position: ChrX, 68.46 cM
|
| Alliance: |
Alas2em4Mdf page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Not Applicable) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: Alas2 ins14 mice carry a 14 bp insertion in exon 11 of the X-linked mouse Alas2 gene that creates a frameshift. This viable C-terminal mutation allele was incidentally created during the targeting of Alas2em3Mdf. The insertion (c.1646_1647ins14 (CGAAGAAGTTAAGA), p.Val550Glufs*23) was introduced as part of non-homologous end joining (NHEJ) CRISPR/cas9 processes in C57BL/6NCrl blastocysts (sgRNA: GCATGTGTTTGACATTGCGC).
(J:358328)
|
|
|
|
|
| Original: |
J:358328 Ducamp S, et al., Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine. Blood. 2024 Sep 26;144(13):1418-1432 |
| All: |
1 reference(s) |
|